We are international
Donate
• IMF TV TEXT SIZE   
IMF Webcasts

Featured Videos
International Myeloma Working Group
Patient & Family Seminar Webcasts
IMF Webcasts from Medical Meetings
Myeloma Information
Teleconferences
Recent FDA Approved Treatments for Myeloma
Dr. Rafat Abonour, Director, Multiple Myeloma Program at Indiana University Simon Cancer Center, and IMF Medical Liaison, speaks about myeloma drugs recently approved by the US Food and Drug Administration (FDA) and their real-world impact in the US. With many of these drugs slated for approval or use in clinical trials around the world, tune into this free webinar to hear about treatments that could soon be available
NIH Funding: How It Benefits You as a Patient

The webinar focuses on the importance of advocating for research funding at the National Institutes of Health (NIH), specifically how certain programs, such as grants for young, emerging researchers and funding for clinical trials, impact myeloma patients. Also discussed will be how you can get involved in advocacy activities to help increase funding and spur new advances in scientific research that will benefit you as a patient. 


Increasing Patient Access to Oral Rx Cancer Treatments in Alaska

The webinar will explain the oral parity issue in detail, what the proposed legislation would do, and how advocates can get involved. It is really important that we have as many advocates attend the webinar as possible. As one of our awesome Alaska advocates I was hoping you would be interested in attending, and could spread the word about the event to your friends and family.

Living Well with Multiple Myeloma Teleconferences
The IMF’s Living Well with Myeloma quarterly teleconference series is designed to cover all the important and most up to date information regarding multiple myeloma.

Best of ASH 2015
What Patients and Caregivers Need to Know

Join Dr. Brian G.M. Durie as he discusses the latest news from the 57th American Society of Hematology (ASH) Conference which recently convened in Orlando, FL on December 5-7th.

Understanding Clinical Pathways

Clinical Pathways are a mechanism used by insurers to make health care costs more predictable by prescribing a course of treatment in which the type and timing of specific therapies are pre-determined. The presentation will go over how pathways are developed, so that you can make more informed decisions about your care. It will also cover how to talk to your physician about how these pathways are structured within their practices and whether they have placed you on a particular pathway. 


Multiple Myeloma and VA Benefits

Learn more about strategies for veterean's to maxmize access to VA support.

The Military Veterans Perspective on Living with Multiple Myeloma

Learn more about how veterans with multiple myeloma deal with the disease and how they navigate the VA and other agencies to optimze their resources.  Sandy Kurtin would also discuss the results of the Veteran's Against Myeloma focus group and touch on the current trends in Multiple Myeloma diagnosis & treatment.


Myeloma Updates 2015 Post ASCO/EHA/IMWG

Learn more about current trends in myeloma treatment and research with this update from three major medical meetings held in June 2015. Dr. Brian G.M. Durie will explain what's new and exciting from the American Society of Clinical Oncology (ASCO), the European Hematology Association (EHA), and the International Myeloma Working Group Summit (IMWG).

Best of ASH 2014 - What Patients Need to Know

Join Dr. Brian G.M. Durie as he discusses the latest news from the American Society of Hematology (ASH) Conference which recently convened in San Francisco on December 6-8th.

The ASH annual meeting is the largest global blood cancer meeting, featuring over 3,000 scientific abstracts, and was attended by more than 20,000 medical professionals.


Medicare 101 Webinar

The IMF Advocacy team hosted a webinar, Medicare 101, on Medicare access. Guest speaker Dr. Gretchen Jacobson, Associate Director with the Kaiser Family Foundation’s Program on Medicare Policy, provided a wealth of information on the Medicare enrollment process and types of coverage.

 

 

Myeloma Updates 2014: Post ASCO/EHA/IMWG

Learn more about current trends in myeloma treatment and research with this update from three major medical meetings held in June 2014. Dr. Brian G.M. Durie will explain what's new and exciting from the American Society of Clinical Oncology (ASCO), the European Hematology Association (EHA), and the International Myeloma Working Group Summit (IMWG)


Best of Ash 2013: What Patients Need to Know
Join IMF Chairman Brian G.M. Durie, MD, in a teleconference and Q&A on January 16 7pm ET/ 4pm PT as he highlights key information he has gleaned from over 800 myeloma abstracts presented at the 2013 annual meeting of the American Society of Hematology (ASH) that will have the biggest impact on myeloma patients, now and in the future.
Myeloma Updates 2013 Post ASCO/EHA/IMWG
Learn more about current trends in myeloma treatment and research with this update from three major medical meetings held in June 2013. Dr. Brian G.M. Durie will explain what’s new and exciting from the American Society of Clinical Oncology, the European Hematology Association, and the International Myeloma Working Group Summit

Health Reform and You: The ABC’s of the ACA for Private Health Insurance
Cancer patients and family members who want to learn about health care reform and how it will affect them, and in particular uninsured or under-insured individuals, and people interested in purchasing individual or small group health insurance through the newly created health insurance marketplaces.
What’s NEW with Novel Therapies?
With Dr. Brian Durie and Dr. Sagar Lonial
Teleconference originally aired on February 21, 2013

Nurse Leadership Board Teleconferences
Myeloma Manager™ Webinar Replay
If you missed the Webinar about the IMF's Myeloma Manager™ Personal Care Assistant™, we have a replay of our last Webinar, held on January 28, 2009, with everything you need to know about this incredible tool for tracking lab results, treatment regimens, and so much more.

Teleconference: Myeloma Updates 2012
Post ASCO/EHA/IMWG Summit
280 patients, family members, caregivers and healthcare professionals participated in this teleconference. Listen to an audio recording and view the slides.
The Emerging Role of Kyprolis in the Treatment Paradigm
The IMF's Dr. Brian G.M Durie and Dr. Tom Martin of the University of California San Francisco discuss the emerging role of Kyprolis in the treatment paradigm.

The Importance of Clinical Trial Participation - A teleconference with Dr. Brian G. M. Durie
September 8,2011
Dr. Durie is National Director for Hematologic Malignancies for Aptium Oncology and Specialist in Multiple Myeloma and Related Disorders for Cedars-Sinai Outpatient Cancer Center in Los Angeles, CA
IMF Teleconference Archive